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Abstract  
 27 
Juvenile barramundi were fed one of six diets containing differing docosahexaenoic acid (DHA) and 
eicosapentaenoic acid (EPA) levels. Fish were fed on a pair-fed feeding regime to eliminate 
variability in feed intake, with two diets fed to satiety to examine the effects of fixed or variable feed 30 
rations on EFA requirements. Weight gain, feed intake, feed utilisation, and physical clinical signs 
were monitored. No effect of dietary DHA and EPA concentration, DHA:EPA ratio or total LC-
PUFA level was observed on weight gain, growth rate, feed conversion ratio (FCR), survival or 33 
physical clinical health signs. Satiety fed fish had higher feed intake, final weight, weight gain and 
growth rate compared to their respective restrictively fed treatments (P<0.05). No effect of ration 
level on the responses to DHA concentration was observed. Body fatty acid composition was affected 36 
by diet, increasing dietary DHA resulted in higher body tissue DHA concentration, and a similar 
relationship was observed for EPA. Plasma haemoglobin increased with increasing DHA+EPA levels 
(P<0.05) while glutamate dehydrogenase increased for fish fed DHA+EPA in a 1:1 ratio, regardless 39 
of total dietary LC-PUFA (P<0.05). Juvenile barramundi may be fed diets containing as low as 1 g kg-
1 DHA without compromising growth or health status. 
42 
 3 
1.1 Introduction 
 
Traditionally, commercial aquaculture diets have relied on marine fishery oils for their lipid 45 
component as they were readily available, competitive in price and contained the essential fatty acids 
required by fish (reviewed by Turchini et al., 2009). Increasing aquaculture production continues to 
place demands on static global wild fish resources, making their continued use unsustainable (Tacon 48 
& Metian, 2008). To meet global aquaculture demands, a number of alternative lipid resources have 
been trialled including vegetable oils (such as palm oil, soybean oil, canola oil and rapeseed oil) and 
animal fats (such as lard, poultry oil and tallow; Turchini et al., 2009). However, all of these 51 
alternative lipid sources are non-marine and lack long-chain polyunsatured fatty acids (LC-PUFA). 
 
Some freshwater species have little or no requirement for dietary LC-PUFA. However, the majority of 54 
aquatic marine species have a defined dietary requirement for LC-PUFA (reviewed by Glencross, 
2009). This probably results from an evolutionary adaptation to naturally LC-PUFA rich diets, 
resulting in many marine species losing their ability to convert C18 n-6 and n-3 PUFA into the 57 
corresponding C20 and C22 n-3 and n-6 HUFA in vivo by alternating cycles of desaturation and 
elongation (Tocher, 2010). Marine and catadromous species, including barramundi, have been 
demonstrated to have an absolute dietary requirement for the longer, and more unsaturated 20:5n-3 60 
(EPA) and 22:6n-3 (DHA; Buranapanidgit et al., 1988; Williams et al., 2006; Glencross and 
Rutherford, 2011). A total n-3 LC-PUFA inclusion level of between 10 - 17 g kg-1 (as a combination 
of 20:5 n-3 and 22:6 n-3) was sufficient to support growth of barramundi (Buranapanidgit et al., 1988, 63 
1989 cited by Boonyaratpalin, 1997). Later work by Williams et al. (2006) found little effect of 
dietary LC-PUFA level on growth but observed that some fish exhibited a ‘fainting’ response, a 
reported sign of EFA deficiency in other fish when fed an LC-PUFA free diet containing 2 % lipid 66 
(made up of varying amounts of lauric, linoleic and linolenic acids; Castell et al., 1972).  In a 
subsequent study, Glencross and Rutherford (2011) hypothesised a quantitative requirement of around 
10 g kg-1 DHA for barramundi. The authors did not observe an effect of DHA inclusion levels on 69 
growth parameters, even at inclusion levels as low as 1 g kg-1. Although in that study all diets were 
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pair-fed restrictively and it is unclear as to what effect that this feed ration regime had on the 
outcomes of the study. However in that study, a subcutaneous haemorrhaging, observed as a 72 
reddening of the skin certain parts of in fish, occurred as dietary DHA levels increased from 1 to 18 g 
kg-1, which was ameliorated by the inclusion of 10 g kg-1 EPA. These results highlighted the 
importance not only of the absolute dietary inclusion level, but also the influence of other EFAs in the 75 
diet. The authors concluded, based on their study and that of Williams et al. (2006) that the total LC-
PUFA inclusion level for barramundi could be reduced to at least 12 g kg-1 provided the DHA and 
EPA are held in balance (i.e. a 1:1 ratio). However, it was suggested that further research was 78 
required to better define the EPA requirements, and the optimal ratio of DHA:EPA in the diets of 
barramundi.  
 81 
To address some of these questions an experiment was conducted to examine the effects of different 
DHA and EPA inclusion levels, total LC-PUFA inclusion levels and the effects of fixed or satietal 
rations, to further refine the understanding of the requirements of LC-PUFA by barramundi.  84 
 
1.2 Materials and Methods 
 87 
1.2.1 Experiment Overview 
This study consisted of six dietary treatments of a range of inclusion levels of DHA both with and 
without EPA (Table 1). Each of these diets was restrictively pair-fed to eliminate effects of feed 90 
intake variation as a secondary variable. Two additional treatments consisted of those diets containing 
1 g kg-1 DHA + 1 g kg-1 EPA and 10 g kg-1 DHA + 1 g kg-1 EPA, which were each fed to apparent 
satiety. These additional treatments were included to measure the effect of varying feed intake on the 93 
results achieved relative to the pair-fed strategy.  All the procedures described herein were approved 
by CSIRO’s Animal Ethics Committee (A3/2012) and performed in accordance with the Australian 
Code of Practice for Care and Use of Animals for Scientific Purposes.  96 
 
1.2.2 Animal management 
 5 
Juvenile barramundi (Lates calcarifer) were sourced from Betta Barra (Cairns, QLD, Australia) and 99 
on-grown in a 10,000 L tank and fed a commercial diet (Marine Float, Ridley Aquafeed, Narangba, 
Qld, Australia). At the commencement of the experiment, fish (n=480; 16.5 ± 0.1 g, mean ± S.D.) 
were anesthetised with AQUI-STM (0.02 mL L-1; AQUI-S New Zealand, Lower Hutt, New Zealand), 102 
weighed on an electronic top-loading balance to 0.1 g accuracy and allocated to one of 24 aquaria 
(300 L; n=20 fish per aquaria) housed at the Aquaculture Feed Technology Laboratory at the Bribie 
Island Research Centre. Aquaria were supplied with flow-through seawater (salinity = 35 PSU; 105 
dissolved oxygen 7.0 ± 0.01 mg L-1) at a rate of 4 L min-1, maintained at 28.9 ± 0.6ºC (mean ± S.D.) 
for the duration of the experiment (28 days). Treatments were randomly allocated to 24 tanks, with 
each treatment having three replicates.  108 
 
1.2.3 Diet preparation and management 
A series of six diets, three with different DHA and three with different DHA+EPA inclusion levels 111 
were created by blending a range of ingredients including defatted fishmeal, an algal derived DHA 
source, fish oil, olive oil and butter fat to provide the lipid (Table 1).  
 114 
Diets were formulated to provide approximately 540 g kg-1 protein and 100 g kg-1 of lipid at a gross 
energy level of 20.0 MJ kg-1 (estimated digestible protein and energy of 500 g kg-1 and 17.0 MJ kg-1 
respectively; Table 2). Diets were manufactured by making a single 40 kg batch of extruded pellets 117 
before an oil coating was applied under vacuum to each treatment. Dry ingredients were mixed using 
an upright planetary mixer (Robo Coupe, Vincennes Cedex, France). 
 120 
Following dry mixing, the base diet was extruded using an APV MFP24 laboratory scale twin-screw 
extruder (APV-Baker, Peterborough, UK) using the operational configuration as described in 
Glencross et al. (2012). The pellets were produced by delivering the dry mash into the barrel at a feed 123 
rate of around 20 kg h-1. Barrel temperatures were set for each of the four zones from drive to die at 
50, 80, 100 and 110°C respectively. Water was peristaltically pumped (Baoding Longer Precision 
Pump Co., Ltd, Hebei, China) into the barrel at 82 mL min-1. Feeds were extruded through a 4mm Ø 126 
 6 
die with the machine running at c. 470 rpm. Pellets were cut into 6-7 mm lengths using two-bladed 
variable-speed cutter and collected on large aluminium oven trays (650 x 450 x 25 mm, length x 
width x depth). Approximately 40 kg of a single basal formulation of the resulting pellets were 129 
collected and dried at 65°C prior to coating with oil. 
 
Specific lipid allocations, consisting of blends of butter, olive oil, DHA oil and fish oil (Table 1), 132 
were vacuum-infused into the pellets after warming both the oils and pellets in an oven at 60°C for 1 
h. Warmed pellets were then placed in a Hobart mixer and the prescribed oil blend for each treatment 
was poured over the pellets whilst mixing. After mixing, the pellets were then exposed to a vacuum 135 
through the application of a perspex lid with a rubber seal to the mixing bowl and a vacuum pump 
connected to a valve in the lid. After all pellets were vacuum-infused with their respective oil blend, 
the pellets were stored at -20°C until required for feeding.  138 
 
Fish were fed once daily between 0900 and 1030 each day. The fish were fed diets in a restricted pair-
fed regime to minimise feed intake variability among treatments, thereby ensuring that any effects 141 
seen on the fish were due solely due to diet composition and not possible confounding intake 
variability effects. Any uneaten feed was accounted for to accurately determine feed intake by each 
tank of fish (Helland et al., 1996). A correction factor was applied to recovered uneaten pellets to 144 
account for soluble losses incurred on the pellet between feeding and collection to make a more 
accurate feed intake assessment. The initial restrictive rations were defined based on the feed demand 
as estimated for a 17.0 MJ kg-1 diet and fish of 16 g at 30ºC using a published bioenergetic model for 147 
this species (Glencross, 2008). 
 
1.2.4 Sample preparation and analysis 150 
At the beginning of the study, five fish, representative of the initial population, were euthanized by an 
overdose of AQUI-STM and frozen at -20°C until subsequent composition analysis. At the conclusion 
of the experiment, after the final weighing, three fish from each tank were euthanized as described 153 
above before being stored at -20°C until subsequent composition analysis. An additional three fish per 
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tank were also euthanized. Blood samples were collected from the caudal vein using a 3 mL syringe 
and 18G needle pre-loaded with 0.5 M EDTA. Whole blood was then split into two aliquots, 156 
transferred into a 1.5 mL EppendorfTM tube and stored at 4°C (prior to haematological analysis), or 
transferred into a 1.5 mL EppendorfTM tube and centrifuged (1000 x g; 3 mins). After centrifugation, 
the plasma was transferred to a new EppendorfTM tube prior to being snap-frozen at -80°C. 159 
 
1.2.5 Chemical and compositional analysis 
All chemical and compositional analyses were performed in-house. Diet and whole-fish samples were 162 
analysed for dry matter, ash, nitrogen, total lipids, fatty acids and gross energy content. Dry matter 
was calculated by gravimetric analysis following oven drying at 105ºC for 24 h. Protein levels were 
calculated from the determination of total nitrogen by CHNOS auto-analyser, based on N x 6.25. 165 
Total lipid content of the diets was determined gravimetrically following extraction of the lipids using 
chloroform: methanol (2:1) described by Folch et al. (1957). Gross ash content was determined 
gravimetrically following loss of mass after combustion of a sample in a muffle furnace at 550C for 168 
12 h. Gross energy was determined by adiabatic bomb calorimetry. Fatty acids were analysed as 
methyl ester derivatives. Lipids were esterified and analysed by gas chromatography (GC) using 
flame ionisation detection. Peaks were identified by comparing relative retention times to standards.  171 
 
Samples of whole fish combined by tank, were dried of residual surface moisture and minced 
together. For mincing, samples were passed twice through an industrial food processor to ensure 174 
sample homogeneity. A sub-sample of mince was taken for dry matter analysis and an additional 
mince sub-sample was then frozen prior to being freeze-dried. Freeze-dried mince samples were 
milled and then analysed for dry matter, nitrogen, ash, total lipid, fatty acids and energy as described 177 
above.  
 
1.2.6 Haematology and plasma biochemistry 180 
Whole blood and plasma samples were sent to an independent laboratory for analysis (West 
Australian Animal Health Laboratories, South Perth, Western Australia). Haematological analysis 
 8 
included packed cell volume (PCV) and erythrocyte fragility. Packed cell volume was determined 183 
using standard pathology laboratory procedures and erythrocyte fragility measured by percent 
haemolysis when red cells were placed in a 0.6 g/L sodium chloride solution. Plasma samples 
subjected to the clinical chemistry panel, with assays run on an Olympus AU400 automated chemistry 186 
analyser (Olympus Optical Co. Ltd). Each of the assays used was a standard kit developed for the 
auto-analyser. The tests performed included Alanine Aminotransferance (ALT; Olympus kit Cat. No. 
OSR6107), Glutamate Dehydrogenase (GLDH; Randox kit Cat. No. GL441), Total Protein (Olympus 189 
kit Cat. No. OSR6132), Creatinine (Olympus kit Cat. No. OSR6178), and Haem (Randox test kit Cat. 
No. HG1539). Trace elements were determined after mixed acid digestion using inductively coupled 
plasma atomic emission spectrophotometry (ICP-AES).  192 
 
1.2.7 Statistical analyses 
All figures are mean ± SEM unless otherwise specified. Statistical differences were determined by 195 
ANOVA and means compared using least significant differences using GenStat (Release 14, VSN 
International, Hemel Hempstead, UK) with P<0.05 considered significant. Additionally, the effect of 
ration level and diet were also analysed by two-way ANOVA using GenStat (Release 14, VSN 198 
International, Hemel Hempstead, UK) with P<0.05 considered significant. 
 
The retention of specific fatty acids (DHA and EPA) was calculated using the formula described by 201 
Glencross et al. (2003). Briefly, the percentage retention of fatty acids was calculated using the 
average feed intake per fish in each tank and the average gain in mass of each fatty acid by fish using 
the formula: 204 
 
Where FAf is the absolute amount of a specific fatty acid in the fish at the end of the study, FAi is the 
absolute amount of that specific fatty acid in the fish at the beginning of the study, and FAc is the 207 
amount of that specific fatty acid that the fish consumed over the study period. 
Fatty Acid Retention (%)    
FAf    FAi
FAc
    100








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1.3 Results 
 210 
1.3.1 Fish growth and feed utilisation  
Initial and final fish weights, growth rate, feed intake, feed conversation ratio and survival parameters 
are presented in Table 3. The poorest performing treatment increased their weight by 171% and the 213 
best performing treatment increased their weight by 245% (Table 3). Among the restricted fed groups, 
there was no effect of dietary DHA or EPA level on final weight, weight gain or growth rate. 
However, final weight, weight gain and growth rate were higher (P<0.05) for the two satiety fed 216 
groups, compared with the restricted fed groups, reflective of their greater (P<0.05) feed intake. There 
was no interaction between feeding regime (restricted or satiety) and dietary DHA levels (P>0.05). 
Feed conversion and survival were all unaffected (P>0.05) by dietary DHA and EPA levels and 219 
feeding regime (restricted or satiety).  
 
1.3.2 Tissue composition and fatty acid retention  222 
Dietary treatment significantly affected whole body fatty acid composition in the fish (P<0.05; Table 
4). Compared with the initial fish, the majority of dietary treatment groups showed a reduction in 
whole body DHA (P<0.05) although fish fed diet D10E1 showed an increase in whole body DHA 225 
compared with the initial fish (P<0.05). For restricted fed fish, increasing dietary DHA resulted in an 
increase in the observed whole body DHA, with the highest levels observed in fish fed diet containing 
D10E1 (P<0.05), followed by fish fed diet D5E1 (P<0.05) while the fish fed diets D3E1 and D1E1 228 
did not differ from each other in whole body DHA content (P>0.05). However, the whole body DHA 
content of these two groups was significantly lower than the D10E1 and D5E1 diet fed fish (P<0.05). 
Fish from the D10E1 satiety fed treatment contained less (P<0.05) tissue DHA than the D10E1 231 
restricted fed group, although similar whole body DHA levels were observed for the restricted and 
satiety fed D1E1 (P>0.05). 
 234 
A similar relationship was observed for EPA, in that most dietary treatments resulted in lower tissue 
EPA compared with the initial fish (P<0.05). The highest (P<0.05) tissue EPA levels were observed 
 10 
in fish fed diets containing E10D10, which was increased compared with the initial fish (P<0.05). The 237 
next highest tissue EPA levels were observed in fish fed the D3E3 and D5E5 treatments that had 
similar tissue EPA levels (P>0.05). The lowest tissue EPA was observed in fish fed the D1E1 diet and 
was similar regardless of the DHA content of the diet (P>0.05) and feeding regime (restricted vs 240 
satiety; P>0.05). 
 
Total tissue SFA increased compared with the initial fish (P<0.05) and was similar across most 243 
treatment groups (range: 38.8 – 40.1%) except that tissue SFA was significantly increased for the 
D10E1 restricted and satiety fed groups as well as the D1E1 satiety fed group (P<0.05). Total tissue 
MUFA was similar for the initial fish and the D1E1 and D3E3 restricted fed groups (P>0.05), but was 246 
increased (P<0.05) for the D5E1, D10E10, D5E5 and both satiety fed groups (D1E1 and D10E10). 
 
Significant differences were observed in whole body PUFA between treatments (P<0.05), with PUFA 249 
concentration increasing with dietary DHA and EPA content for fish on the restricted feeding regime.  
Compared with the initial fish, both satiety fed groups (D1E1 and D10E10) showed reduced levels of 
whole body PUFA along with most of the restricted fed fish, with the only group containing 252 
significantly more PUFA than the initial fish being the D10E10 diet fed fish. The total LC-PUFA 
content ranged from 9.4 – 14.6% (P<0.05), and increased with increasing dietary LC-PUFA content. 
Compared with the initial fish, only the D10E1 and D10E10 dietary treatments showed an increase 255 
(P<0.05) in tissue LC-PUFA content, all other groups showed a significant reduction in tissue LC-
PUFA content (P<0.05). 
 258 
Tissue n-3 levels were significantly lower for all dietary treatments compared with the initial fish 
(P<0.05). Tissue n-3 levels were increased (P<0.05) by increasing dietary DHA, as well as the 
combined concentration of DHA + EPA concentration in the diet (P<0.05). However, feeding regime 261 
(restricted vs satiety) did not affect tissue n-3 levels (P>0.05). Tissue n-6 levels were similar between 
the initial fish and all fish fed diets with greater than 1 g kg-1 DHA (D1E1). However, the addition of 
10 g kg-1 EPA to the 10 g kg-1 DHA diet (D10E10) reduced (P<0.05) the total tissue n-6. Compared 264 
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with the initial fish, all fish fed diets containing greater than 1 g kg-1 EPA had reduced tissue n-6 
levels (P<0.05). Again, feeding regime (restricted vs satiety) did not affect tissue n-6 levels (P>0.05). 
 267 
Retention of DHA and EPA is presented in Table 4. Retention efficiency was affected by dietary 
treatment for both DHA and EPA (P<0.05). For DHA, retention efficiency was highest (80%) for 
satiety fed fish receiving the lowest DHA inclusion level (1 g kg-1) followed by the restricted fed fish 270 
receiving diets with 1g kg-1 and 5 g kg-1 DHA (P<0.05) and then the fish receiving the highest DHA 
inclusion level (10 g kg-1; P<0.05). Feeding regime (restricted vs satiety) affected DHA retention, 
which was higher for satiety than restricted fed fish at the lower DHA inclusion level (1 g kg-1) but 273 
was similar (P>0.05) for fish receiving diets containing 10 g kg-1 DHA. DHA retention was also 
reduced when DHA and EPA were included at a 1:1 ratio, and the retention efficiency decreased with 
increasing total DHA + EPA concentration (P<0.05). 276 
 
The retention efficiency of EPA was also affected by dietary treatment. EPA retention was highest for 
groups containing 1 g kg-1 EPA, regardless of the DHA inclusion level, although it did differ between 279 
these groups (P<0.05). EPA retention was affected by feeding regime in a similar way to DHA; 
retention was increased by satiety feed at the 1 g kg-1 DHA + 1 g kg-1 EPA inclusion (D1E1) but was 
not different for the 10 g kg-1 DHA + 1 g kg-1 EPA inclusions levels (diet D10E1). EPA retention was 282 
also affected by DHA: EPA ratio, as well as total DHA + EPA content. When EPA is included at a 
1:1 ratio with DHA, the retention efficiency of EPA is reduced (P<0.05). 
 285 
1.3.3 Plasma chemistry 
Haematology and plasma chemistry parameters are presented in Table 5.  Dietary DHA and EPA 
inclusion levels did not affect haematological parameters such as PCV or erythrocyte fragility. 288 
However, glutamine dehydrogenase and haemoglobin levels were affected by dietary treatment. 
Glutamate dehydrogenase was significantly increased in fish that were fed DHA and EPA in a 1:1 
ratio, regardless of the total dietary PUFA content (P<0.05) as well as being increased by satiety 291 
feeding compared with the restricted fed groups (P<0.05).  
 12 
 
For fish fed diets containing 1 g kg-1 EPA, increasing DHA content resulted in an increase in 294 
haemoglobin (P<0.05). However, for fish fed DHA and EPA at a 1:1 ratio, the picture is less clear 
with the 10: 10 g kg-1 inclusion diet resulting in the highest haemoglobin levels, the D5E5 diet with 
the lowest and the D3E3 diet with an intermediary level. Haemoglobin levels were not affected by 297 
feeding regime (P>0.05) and there were no significant differences in haptoglobin levels. 
 
1.4 Discussion 300 
 
1.4.1 Fish growth and feed utilisation  
Weight gain, growth rate and feed conversion in the present study were not affected by dietary DHA 303 
content, DHA: EPA ratio or the total LC-PUFA content for fish fed a restricted ration. Fish fed to 
satiation showed an increased weight gain and growth rate, reflecting their higher feed intake rather 
than ratio of DHA: EPA or total LC-PUFA content. Despite having different DHA inclusion levels (1 306 
g kg-1 and 10 g kg-1) the satiety fed groups had similar feed intake, weight gain and growth rate. These 
results are in agreement with previous studies that show no link between dietary DHA content and 
growth in restricted (Glencross and Rutherford, 2011) or satiety fed fish (Williams et al., 2006).  309 
 
Glencross and Rutherford (2011) found that the addition of EPA to the diet (10 g kg-1 EPA) resulted 
in significantly higher growth rates than the two lowest (1 and 3 g kg-1) and two highest DHA 312 
inclusion levels (15 and 18 g kg-1). However, in the present study there was no difference in growth 
rates observed when fish were fed diets containing 10 g kg-1 DHA in the absence of EPA (D10E1), or 
with a 1:1 ratio of EPA (D10E10). This lack of effect of EPA addition on growth could be a result of 315 
the shorter duration of the present study (28 days) compared with Glencross and Rutherford (2011; 42 
days), reflecting a reduction in the biological (mass) turnover. However, despite the shorter duration, 
both trials used fish of a similar initial size (present study: 16.2-16.4 g, or 17.3-17.6 g for Glencross 318 
and Rutherford, 2011) and grew them until approximately three times their initial weight. Growth 
rates in the present study (range: 3.6 - 3.7%) were higher than those observed (range 2.1 - 3.1%) by 
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Glencross and Rutherford (2011), suggesting that differences in biological turnover are not 321 
responsible for differences between the studies. Using post-smolt Atlantic salmon, Glencross et al. 
(2013) demonstrated that the fish fed on an EFA-free diet (1 g kg-1 inclusion level) maintained 
performance for five weeks before a dramatic and sudden decline in survival. This suggests that the 324 
effects of dietary EFA could be a function of absolute time rather than just biological turnover. 
 
One of the more novel aspects of the present study was the examination of various DHA: EPA ratios, 327 
as well as varying total LC-PUFA content. The majority of studies examining EFA requirements have 
focussed on the total EFA level relative to lipid content of the diet, or the total n-3 LC-PUFA 
requirements (reviewed by Glencross, 2009). For barramundi, the optimal total n-3 LC-PUFA level 330 
has been suggested by Glencross and Rutherford (2011), based on the studies of Williams et al. 
(2006) to be 12 g kg-1 provided that DHA and EPA are held in balance (1:1 ratio). However, when the 
DHA: EPA were in balance (1: 1 ratio), the total LC-PUFA could be reduced to 4 g kg-1 without 333 
detrimental effects on growth, suggesting that when DHA and EPA are in balance, the LC-PUFA 
requirement is considerably lower than 12 g kg-1.   
 336 
When the DHA: EPA ratio was extended to 5: 1 (total LC-PUFA 7 g kg-1) no effect on growth was 
observed, and for higher LC-PUFA levels (greater than 12 g kg-1), again no effect on growth was 
observed, even when the ratio was 10: 1. In juvenile Gilthead seabream (Kalogeropoulos et al., 1992; 339 
Ibeas et al., 1996) and European seabass (Skalli and Robin, 2004) the best growth occurs within a 
narrow range of DHA: EPA ratios (1:1 or 1:2). However, the results of the present study clearly show 
little effect on growth of either the DHA: EPA ratio or total dietary LC-PUFA concentration, possibly 342 
reflecting species differences. For two closely related species (Atlantic salmon and Rainbow trout) 
considerable variation in the LC-PUFA requirements have been demonstrated; Atlantic salmon grew 
best with 10 g kg-1 LC-PUFA (Ruyter et al 2000), while Rainbow trout, grew best with 3 g kg-1 LC-345 
PUFA (Watanabe and Takeuchi, 1976). However, any species influence on the optimal DHA: EPA 
ratio remains unknown. 
 348 
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Differences in dietary lipid levels in the aforementioned studies also confounds the interpretation of 
the absolute LC-PUFA requirements as dietary lipid level is known to influence EFA and therefore 
LC-PUFA requirements in fish (Rainbow trout: Takeuchi and Watanabe, 1977a,b) and shrimp 351 
(Glencross et al., 2002). Nevertheless, the results of the present study highlight the possibility that the 
total LC-PUFA requirement and the ratio of DHA: EPA may not be as important for the growth of 
juvenile barramundi as previously suggested in the literature. Further studies, with a duration of 354 
longer than six weeks, examining further reductions in the dietary LC-PUFA concentration in 
conjunction with differing DHA: EPA ratios are required to fully elucidate the roles of both LC-
PUFA content and DHA: EPA ratio on the growth of juvenile barramundi. Indeed a more 357 
comprehensive study better defining the aetiology of essential fatty acid deficiency in this species is 
warranted given the vagaries in observations seen among a range of studies (Glencross and 
Rutherford, 2011; Williams et al., 2006). 360 
 
1.4.2 Tissue composition and fatty acid retention 
Tissue fatty acid composition was altered by diet, which has been previously demonstrated for a 363 
number of fish species (reviewed by Glencross, 2009). Compared with the initial fish, the majority of 
dietary treatments showed a reduction in tissue DHA and tissue EPA which is in contradiction to 
previous studies in barramundi (Glencross and Rutherford, 2011) but consistent with results in post-366 
smolt Atlantic salmon fed diets containing similar DHA and EPA levels (Glencross et al., 2013).  
 
Examination of the mass-balance relationship between dietary and tissue fatty acids shows a contrast 369 
with previous studies in barramundi (Glencross and Rutherford, 2011) and Atlantic salmon 
(Glencross et al., 2013). Both studies demonstrated high (>100%) DHA retention levels when fish 
were fed diets low in DHA, suggesting high-level conservation and or possible synthesis of DHA was 372 
occurring. Atlantic salmon possess this capability (Tocher, 2003) although it is generally believed that 
barramundi are not able to synthesise DHA and the results of the present study support this.  
 375 
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Despite differences in the magnitude of DHA and EPA retention between the present study and those 
of Glencross and Rutherford (2011) and Glencross et al. (2013), a similar pattern of retention was 
observed. In all three studies, DHA retention was highest at the lowest DHA inclusion level, reducing 378 
as dietary DHA increased, consistent with previous studies (Bell et al., 2002; Torstensen et al., 2004; 
Stubhaug et al., 2007). 
 381 
The pattern of EPA retention is less clear, with retention being higher at dietary DHA levels of 5 g kg-
1 or less, contrasting with previous studies (Glencross and Rutherford, 2011; Glencross et al., 2013). 
EPA retention improved substantially with increasing dietary DHA (Glencross and Rutherford, 2011) 384 
but this was not observed in the present study. In the present study, increasing dietary DHA, 
decreased EPA retention and the addition of EPA to the diet further reduced EPA retention. Glencross 
et al. (2013) demonstrated reduced EPA retention levels when EPA was added to the diet but 387 
observed increasing EPA retention until dietary DHA reached 10 g kg-1, in contrast with the present 
study. Negative EPA retention values at both low and high DHA inclusion levels, suggests that chain 
elongation and desaturation was occurring (Glencross et al., 2013). However, low levels of EPA 390 
retention suggest that DHA is not being retroconverted to EPA nor are shorter chain fatty acids being 
elongated to form EPA, contrasting with previous studies (Glencross and Rutherford, 2011) but 
agreeing with Glencross et al. (2003) who demonstrated EPA retention in Red seabream did not 393 
exceed 60% regardless of dietary EPA (Glencross et al., 2003). 
 
Higher levels of DHA and EPA in the initial fish may explain differences between the present study 396 
and that of Glencross and Rutherford (2011). Fish of a similar starting size (17 g) but the initial fish in 
the present study contained 7.6% DHA and 3.4% EPA compared with 3% DHA and 2% EPA for 
Glencross and Rutherford (2011). Glencross et al. (2013) suggested that the effects of EFAs on 399 
growth may be a function of time rather than just mass turnover (discussed previously), it is not 
surprising that the results of the present study differ to that of Glencross and Rutherford (2011) 
considering that the endogenous reserves of DHA and EPA were almost double in the present study. 402 
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1.4.3 Plasma chemistry 
Essential fatty acids, specifically DHA and EPA play a role in the membranes of red blood cells and 405 
diets deficient in EFAs have been associated with perturbations in red cell function including 
increased red cell fragility (Montero et al., 2004). No effect of dietary DHA or EPA concentration or 
total LC-PUFA concentration was observed on the haematological parameters measured (PCV and 408 
erythrocyte fragility). However, there was a large variation between individual fish from the same 
groups suggesting that individual variation is considerably larger than any dietary effect, or that there 
is no effect of dietary fatty acids in these parameters.  411 
 
Of the biochemical markers assessed only glutamate dehydrogenase and haemoglobin were 
significantly affected by dietary treatment. Glutamate dehydrogenase is an enzyme, present in the 414 
mitochondria that converts glutamate to α-ketoglutarate and has roles in transdeamination as well as 
osmoregulation in aquatic animals (by synthesis of proline and alanine; Li et al., 2011). Glutamate 
dehydrogenase activity was not affected by DHA concentration when fish were fed diets containing 1 417 
g kg-1 of EPA agreeing with previous research (Glencross and Rutherford, 2011). When fish were fed 
diets containing greater than 1 g kg-1 EPA glutamine dehydrogenase activity was increased, 
irrespective of the total LC-PUFA inclusion level. Glutamate dehydrogenase activity was also 420 
increased in the satiety fed vs restricted groups, possibly a reflection of the increased feed intake, and 
therefore increased EPA intake. 
 423 
Glutamate dehydrogenase plays an important role in the diagnosis of liver disease, in combination 
with aminotransferases (also examined in this study). Liver disease involving necrosis of the 
hepatocytes resulted in elevated GLDH in conjunction with elevated aminotransferases (Ozer et al., 426 
2008). A concomitant increase in alanine aminotransferase was not observed in this study, suggesting 
that the increase in GLDH was not owing to liver damage, but reflective of the enzymes role in 
osmoregulation. The role of EPA in osmotic regulation and hydration balance has already been 429 
highlighted (Glencross and Rutherford, 2011) with the results of the present study supporting this.  
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Glencross and Rutherford (2011) demonstrated a relationship between plasma urea concentration and 432 
dietary DHA content, which was absent in the present study but may be reflective of the lower plasma 
urea concentrations in the present study (range: 1.0-1.6 mmol L-1) compared with the former (2.3-3.0 
mmol L-1). 435 
 
 Plasma haemoglobin was affected by DHA concentration but not by total LC-PUFA concentration or 
feeding regime (restricted vs. satiety), contradicting Glencross and Rutherford (2011). In Sea bream 438 
an n3-LC-PUFA deficient diet increased total haemoglobin attributing the increase to a reduction in 
erythrocyte volume (Montero et al., 2004). However, haemoglobin increased with increasing DHA 
content in the present study, suggesting that n3-LC-PUFA deficiency was not responsible for this 441 
observation.  
 
Catacutan and Coloso (1995) observed abnormal reddening of the fins, a sign of essential fatty acid 444 
deficiency, in fish fed diets containing less than 5% lipid. Glencross and Rutherford (2011) also 
observed this reddening of fins, identifying it as mild subcutaneous haemorrhaging resulting from a 
reduced ability of the fish to ionically regulate. In this study it was identified that this was linked to 447 
the absence of EPA in the diet, with high levels of DHA exacerbating the problem. In the present 
study this reddening was not observed, suggesting that the EPA inclusion levels were sufficient to 
facilitate ionic regulation, or that residual levels in the fish’s body reserves were adequate to prevent 450 
any subcutaneous haemorrhage (and associated perturbations to ionic regulation; Glencross and 
Rutherford, 2011). Inclusion levels of EPA (1.5 g kg-1) were similar to those of Glencross and 
Rutherford (2011), which ranged from 1.5-3.1 g kg-1 in the diets as were ARA levels (present study 453 
range: 0-1.0 g kg-1; Glencross and Rutherford, 2011 range: 0.2-0.9 g kg-1), suggesting that either the 
ARA content was sufficient to produce sufficient prostaglandin H2 in the present study but not that of 
Glencross and Rutherford (2011). Fish in the present study contained substantially higher tissue levels 456 
of ARA and EPA than those used by Glencross and Rutherford (2011) and utilisation of these stored 
reserves may have contributed to the production of sufficient prostaglandin H2 for ionic regulation. 
Conversely, as the dietary EPA + ARA concentration is less than that of Glencross and Rutherford 459 
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(2011), it raises the possibility that the majority of ionic regulation was mediated through pathways 
other than the prostaglandin hormones, such as gills, kidneys or intestine (Glencross, 2006). Further 
research examining the activity of these pathways is required to confirm this. 462 
 
1.4.4 Implications and conclusions 
Diets containing DHA inclusions levels as low as 1 g kg-1 did not compromise growth or survival of 465 
juvenile barramundi. In contrast to previous studies, the absence of EPA (i.e. levels as low as 1 g kg-1) 
did not result in a range of physiological problems suggesting that further research is required to 
elucidate differences between this study and previous ones. It is generally suggested that DHA and 468 
EPA should be provided in balance although the results of the present study suggest that is less 
important than previously thought. Given the lack of deleterious effects on growth and health of fish 
fed the D1E1 diet, further studies are warranted and should examine lower levels of DHA and EPA 471 
inclusion as well as examining the effect of altering the DHA: EPA ratio beyond 10:1 or below 1:1. 
Given that the response of the juvenile barramundi to low-LC-PUFA diets may be related to time 
and/or turnover, studies should be lengthened and the range of health parameters expanded to fully 474 
assess the longer-term implications on growth and health.  
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Table 1. Formulations and composition of the experiment diets (all values are g kg-1). 
 567 
 Formulated DHA: EPA Content (g kg-1) 
Ingredient D1E1 D5E1 D10E1 D10E10  D5E5 D3E3 
Pregelled wheat starch 50 50 50 50 50 50 
Wheat gluten 80 80 80 80 80 80 
Wheat flour 182 182 182 182 182 182 
Casein 100 100 100 100 100 100 
Soy Protein Isolate 200 200 200 200 200 200 
Fish oil 0 0 0 75 30 15 
Olive Oil 41 37 31 4 26 34 
DHASCO 0 8 20 0 0 0 
Defatted Fish meal  300 300 300 300 300 300 
Butter fat 41 37 31 4 26 34 
Yttrium oxide 1 1 1 1 1 1 
Pre-mix vitamins* 5 5 5 5 5 5 
Cellulose 0 0 0 0 0 0 
 Fatty acids as a per cent of total fatty acids 
Diet composition       
Dry matter 871 963 873 964 967 968 
Crude protein 578 613 574 609 609 632 
Ash 55 65 57 65 66 66 
Lipid 98 85 94 99 105 85 
Gross energy  22.6 22.0 22.3 22.2 22.3 22.2 
14:0 5.8% 5.9% 6.2% 7.1% 6.4% 6.1% 
16:0 19.8% 21.4% 20.4% 20.2% 20.9% 21.4% 
18:0 7.0% 6.0% 5.6% 4.4% 5.3% 5.7% 
SFA 38.4% 38.4% 36.3% 35.2% 36.6% 36.5% 
16:1n7 1.8% 2.2% 2.1% 7.4% 4.7% 3.7% 
18:1n-9 43.9% 36.6% 35.6% 18.9% 29.7 33.4% 
MUFA 46.3% 39.3% 37.9% 26.9% 34.7% 37.4% 
18:2 n6 8.7% 10.4% 9.0% 8.6% 10.1% 11.6% 
18:3n3 1.0% 1.2% 1.0% 1.2% 1.2% 1.3% 
PUFA 15.3% 22.3% 25.9% 37.9% 28.7% 26.2% 
20:4n6 0.2% 0.3% 0.0% 0.9% 0.6% 0.0% 
20:5n3 1.8% 2.7% 2.7% 12.2% 7.3% 5.4% 
22:6n3 2.6% 5.9% 9.8% 11.9% 7.5% 6.5% 
LC-PUFA 4.6% 9.8% 15.2% 25.0% 15.4% 11.8% 
       
n-3 5.9% 10.4% 14.1% 27.3% 17.4% 14.2% 
n-6 9.1% 11.8% 11.8% 9.5% 10.7% 11.5% 
*Vitamin and mineral premix includes (IU kg-1 or g kg-1 of premix): Vitamin A, 2.5MIU; Vitamin D3, 0.25 MIU; Vitamin E, 
16.7 g; Vitamin K3, 1.7 g; Vitamin B1, 2.5 g; Vitamin B2, 4.2 g; Vitamin B3, 25 g; Vitamin B5, 8.3; Vitamin B6, 2.0 g; 
Vitamin B9, 0.8; Vitamin B12, 0.005 g; Biotin, 0.17 g; Vitamin C, 75 g; Choline, 166.7 g; Inositol, 58.3 g; Ethoxyquin, 20.8 570 
g; Copper, 2.5 g; Ferrous iron, 10.0 g; Magnesium, 16.6 g; Manganese, 15.0 g; Zinc, 25.0 g.  
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Table 2. Nutrient composition of key experimental ingredients (all values are g kg-1 DM unless 573 
otherwise indicated). 
 
Nutrient 
Defatted 
Fishmeala 
Olive 
Oilb Casein
c 
Butter 
fatd 
Anchovy 
Oile 
DHASCOf 
Soy Protein 
Isolateg 
Dry matter 
content (g kg-1) 943 
999 995 
999 996 999 995 
Crude protein 713 9.6 939 6.8 78.5 83.2 901 
Total lipid 48 912 8.6 846 929 964 62 
Ash 170 0 48 0 0 0 44 
Gross energy 
(MJ kg-1 DM) 
21.0 43.1 21.6 41.0 38.5 39.1 22.1 
 Fatty acids as a per cent of total fatty acids 
14:0 6.7% 0.0% 11.7% 14.1% 8.3% 9.6% 6.9% 
16:0 22.7% 10.3% 34.4% 32% 18.7% 25.5% 22.3% 
18:0 5.3% 3.2% 14.3% 14.1% 3.4% 0.9% 0.0% 
22:0 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 11.2% 
SFA 38.2% 13.9% 61.9% 68% 35.2% 38% 46.9% 
16:1n-7 7.1% 0.6% 3.2% 0.2% 10.2% 1.8% 6.5% 
18:1n-9 14.3% 74.5% 31.1% 28.7% 12.5% 1.9% 5.4% 
20:1n-9 0.0% 0.3% 0.0% 0.2% 0.0% 0.0% 0.0% 
MUFA 21.3% 77.3% 24.9% 29% 24.2% 4.2% 45.3% 
18:2 n-6 1.8% 8.2% 3.6% 3% 1.4% 0.5% 3.1% 
18:3n-6 0.0% 0.6% 0.0% 1% 0.4% 0.4% 0.0% 
18:3n-3 0.0% 0.0% 0.0% 1.1% 0.7% 0.1% 0.0% 
PUFA 40.5% 8.7% 3.9% 2% 40.6% 57.8% 7.8% 
20:3n-6 0.0% 0.0% 0.0% 0.0% 0.0% 1.0% 0.0% 
20:4n-6 1.5% 0.0% 0.0% 0.0% 1.1% 0.9% 0.0% 
20:3n-3 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 1.30% 
20:5n-3 13.2% 0.0% 0.0% 0.1% 16.9% 1.9% 0.0% 
22:4n-6 0.0% 0.0% 0.0% 0.0% 0.8% 0.0% 0.0% 
22:5n-6 0.0% 0.0% 0.0% 0.0% 0.0% 1.6% 2.3% 
22:6n-3 21.2% 0.0% 0.0% 0.0% 14.5% 50.8% 0.0% 
LC-PUFA 35.9% 0.0% 0.0% 0.1% 33.7% 56.3% 4.1% 
        
n-3 36.2% 0.0% 0.0% 1% 35.1% 55.1% 4.1% 
n-6 3.3% 0.6% 0.0% 2% 3.9% 2.8% 3.7% 
aFish meal (prior to being defatted): Chilean anchovy meal, Skretting Australia, Cambridge, TAS, Australia; bRefined olive 576 
oil: Conga Foods, Coburg North, VIC, Australia; cCasein: Vitamin-free Casein, MP Biomedicals Australia, Seven Hils, 
NSW, Australia; dButterfat: Woolworths Dairies, Bella Vista, NSW, Australia. eAnchovy oil, Skretting Australia, 
Cambridge, TAS, Australia; fDHASCO: HuaTai BioPharm, Deyang, Sichuan, Szechuan, China; gSoy protein isolate: 579 
ADM, Decatur, IL, USA.  
 
 582 
 
 
 585 
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Table 3. Growth and feed utilisation of juvenile barramundi fed diets containing different DHA and EPA levels.  
 588 
Parameter Formulated DHA: EPA Content (g kg
-1)     Pooled 
SEM 
D1E1 D5E1 D10E1 D10E10 D5E5 D3E3 D1E1 Sat D10E1 Sat 
Initial weight (g fish-1) 16.4 16.5 16.4 16.5 16.7 16.3 16.6 16.2 0.05 
Final weight (g fish-1) 45.0a 45.5a 46.2a 44.9a 45.7a 44.6a 56.5b 55.7b 0.4 
Weight gain (g fish-1) 28.6a 29.0a 29.8a 28.4a 29.1a 28.2a 39.9b 39.6b 0.5 
Growth rate* (% d-1) 3.6a 3.7a 3.7a 3.6a 3.6a 3.6a 4.6b 4.6b 0.15 
Feed intake (g fish-1) 24.3a 24.2a 24.4a 23.9a 24.8a 24.1a 34.5b 35.0b 0.3 
Feed Conversion (feed gain-1) 0.85 0.83 0.82 0.84 0.85 0.85 0.86 0.89 0.02 
Survival (%) 100 100 98.3 98.3 98.3 98.3 100 100 0.3 
*Growth rate is daily growth coefficient = (Wf 1/3 – Wi 1/3)/t x 100, where Wf is the final weight Wi is the initial weight and t is time. Different superscripts indicate 
significant differences between means among treatments (P<0.05) and lack of superscripts denotes no significant differences between means among treatments. 
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Table 4. Whole body fatty acid composition and retention of DHA and EPA for juvenile barramundi (data are percent of total fatty acids)  591 
 
Fatty Acid 
Initial 
Fish 
Formulated DHA: EPA content (g kg-1) in diets Pooled 
D1E1 D5E1 D10E1 D10E10 D5E5 D3E3 
D1E1 
Sat 
D10E1 
Sat 
SEM 
           
14:0 3.2a 4.1b 4.1b 3.9b 4.2d 4.1b 4.0b 4.0b 4.0b 0.1 
16:0 21.8 24.7 24.7 24.7 24.8 24.9 24.8 25.2 25.8 0.2 
18:0 6.4a 6.8b 6.5a 6.5a 6.5a 6.5a 6.7b 6.9b 6.8b 0.1 
SFA 34.9a 39.2b,c 38.8b 38.8b 39.9c 39.5b,c 39.3b,c 39.7c 40.1d 0.5 
16:1n-7 6.3a 5.0b 5.1b 5.3c 6.7d 5.9e 5.5f 5.1b 5.1b 0.1 
18:1n-9 30.6a 32.6b 31.3c 29.4a 24.9d 28.9e 31.3c 32.9b 30.1a 0.0 
20:1n-9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 
MUFA 38.3a,b 38.9a 37.6b,e 35.9c 32.9d 36.2b 38.0a 39.2e 36.3b 0.7 
18:2n-6 10.9a 9.7b 9.9b 9.9b 9.5c 9.9b 9.7b,c 9.6c 9.4c 0.7 
PUFA 26.8a 21.9b 23.6c 25.4d 27.3e 24.3c 22.7b,c 21.2b 23.6c 0.7 
20:4n-6 0.9a 0.6b 0.6b 0.6b 0.8c 0.6b 0.6b 0.5d 0.5d 0.02 
20:5n-3 3.4a 2.5b 2.6b 2.8b,e 4.9c 3.6d 3.0e 2.4b 2.4b 0.2 
           
22:6n-3 7.6a 5.6b 6.7c 7.8d 8.1d 6.5c 5.9b 5.2b 7.2c 0.2 
LC-PUFA 12.7a 9.4b 11.0c 12.7a 14.6d 11.5c 10.2b,c 8.9e 11.7b 0.6 
           
n-3 13.3a 9.8b 11.1c 12.5d 15.2e 12.1c,d 10.8b,c 9.4b 11.3c 0.6 
n-6 13.2a 11.9b 12.2a 12.7a 11.8b 12.0b,c 11.7b 11.6b 12.1a 0.2 
           
DHA retention n/a 63.1a 67.3a  33.0b 35.5b 37.3c 40.8c 80.0 d 38.4c 4.1  
EPA retention n/a 40.2a 45.7b 32.6c 25.6d 24.5d 28.1d 51.7
e 39.2a 3.0  
Different superscripts indicate significant differences between means among treatments (P<0.05) and lack of superscripts denotes no significant differences between means 
among treatments. 594 
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Table 5. Haematology and plasma chemistry parameters for juvenile barramundi  
 
Parameter Units 
Formulated DHA: EPA content (g kg-1) in diets Pooled 
D1E1 D5E1 D10E1 D10E10 D5E5 D3E3 D1E1 Sat 
D10E1 
Sat SEM 
PCV % 33.0 33.7 27.7 28.7 29.3 23.3 27.0 31.7 1.25 
Erythrocyte fragility % 72.0 15.0 100 16.3 87.0 57.7 60.0 51.0 4.8 
Total Protein g L-1 39.0 39.3 40.3 43.3 45.0 37.3 40.7 43.3 1.2 
Alanine Aminotransferase U L-1 58.5 98.5 83.5 164.5 145.0 87.0 91.0 50.67 10.1 
Glutamate Dehydrogenase U L-1 10.3a,c 9a 14.7a,c 15.0c,d 15.0c,d 20.0d 17.7d 33.7e 2.0 
Urea mmol L-1 1.5 1.4 1.43 1.0 1.3 1.3 1.5 1.6 0.1 
Creatinine umol L-1 11.7 11.3 12.0 13.0 12.7 11.7 12.7 13.3 0.3 
Cholesterol mmol L-1 2.75 3.1 3.2 2.9 3.0 3.0 2.9 2.8 0.1 
Albumin g L-1 2.8 3.6 3.8 4.1 4.2 3.7 3.1 3.1 0.2 
Calcium (Ca) mmol L-1 1.4 1.4 1.4 0.9 1.1 1.3 1.5 1.4 0.1 
Glycerol mmol L-1 0.14 0.12 0.19 0.06 0.13 0.13 0.20 0.20 0.01 
Iron (Fe) umol L-1 101.9 115.9 80.6 80.2 46.2 124.6 101.8 87.6 7.0 
Haem mg mL-1 232.5a 489.7b,d 449.3b,d 993.0c 243.3a 544.7d 351.0a,b 383.7a,b 44.2 
Haptoglobin mg mL-1 0.12 0.15 0.16 0.25 0.13 0.14 0.13 0.11 0.02 
Different superscripts indicate significant differences between means among treatments (P<0.05) and lack of superscripts denotes no significant differences between means 597 
among treatments. 
 
